Weekly Digests

2026

April

Stopping the shredder to unlock a novel source of valuable neoantigens

April 15, 2026

Inadequate neoantigen presentation in cancer hampers the endogenous antitumor immune response and the efficacy of immunotherapy. One mechanism that limits the production of immune-targetable antigens is nonsense-mediated mRNA decay (NMD). NMD degrades transcripts with premature termination codons (PTCs), eliminating a potential source of frameshift antigens, which may serve as an immune-evasion mechanism in...

KEYSTONE SYMPOSIA: Cancer Immunotherapy: Basic Mechanisms Informing Clinical Application

April 8, 2026

The ACIR team attended the Keystone Symposia on Cancer Immunotherapy: Basic Mechanisms Informing Clinical Application held on March 15-18, 2026 in Quebec, QC, Canada. This week’s extensive special feature covers select talks from the conference. We have organized the content by topics below. (This Keystone Symposia conference is available for On Demand viewing...

LNP mRNA delivery gets a metabolic boost from amino acid supplement

April 1, 2026

Notice: The article we intended to feature this week was briefly delayed in publication. We will share it with you as soon as the embargo is lifted. In the meantime, we encourage you to revisit last week's feature — it's well worth a read. If you've already read it, skip to the bottom of the...

Close Modal

Small change for you. Big change for us!

This Thanksgiving season, show your support for cancer research by donating your change.

In less than a minute, link your credit card with our partner RoundUp App.

Every purchase you make with that card will be rounded up and the change will be donated to ACIR.

All transactions are securely made through Stripe.